Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Sensorium Therapeutics is a drug discovery platform that develops novel FDA-approved psychoactive medicines.
This company is a Boston-based biopharmaceutical company developing immune-based approaches.
RapidPulse is a privately held medical device company that develops minimally invasive vascular products for ischemic stroke
Clearside BioMedical is an ophthalmic company that specializes in the research, development, and commercialization of therapeutic products.
410 Medical is a medical device company dedicated to developing innovative products that enable frontline medical providers to improve care.
Code Biotherapeutics is a next-generation gene therapy company pioneering the development of targeted non-viral gene therapies.
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Ladder Health offers virtual pediatric therapy and support for early childhood developmental delays, including speech and physical therapy.
Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes.
GoCheck, creator of GoCheck Kids, helps primary care networks implement pediatric vision screening.
Shattuck Labs is a biotechnology company that provides novel class biologic medicines for the treatment of cancer and autoimmune disease.
Standard Bariatrics is a medical device company that develops and offers surgical instruments for weight-loss surgeries.
CREATE Medicines is a biotech company developing in vivo CAR therapies using mRNA-LNP immune cell programming technology.
Incyclix Bio develops small molecule inhibitors of CDKs for the treatment of advanced and resistant cancers.
Altis Biosystems is a biotechnology company developing research tools for the pharma and biotech industries.
iVEAcare develops innovative neuromodulation therapy to treat unmet clinical needs.
Pharaoh Neuro develops a neurapheresis cerebrospinal fluid management system for neurological patients.
Boomerang Medical is a bioelectronic medical enterprise.
Mercy BioAnalytics is a biotechnology company that aims to improve and save the lives of people through the early detection of cancer.
GeneCentric Therapeutics develops and commercializes molecular diagnostic tests for oncologists and patients.
Trefoil is a biotechnology company that brings forward novel engineered FGF-1 compounds to treat endothelial cell mediated diseases.
Huma is a provider of business intelligence platform built to automate healthcare through human language.
Atsena Therapeutics is a clinical-stage gene therapy company that develops novel treatments for inherited forms of blindness.
BEKhealth harnesses its AI-powered chart abstraction and patient-matching platform to optimize clinical research enrollment.
Hatteras Venture Partners has invested in 63 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Hatteras Venture Partners's top investment sectors include Health Care, Biotechnology, Therapeutics, Medical, Medical Device. The firm invests across 21 different industry categories.
Among tracked funding rounds, Atsena Therapeutics received $150.0M in a Series C round. Hatteras Venture Partners's total known invested capital is $2.3B.
Hatteras Venture Partners's average investment size is $41.6M across its portfolio of 63 companies.
Recent Hatteras Venture Partners portfolio additions include Sensorium Therapeutics, Boston Immune Technologies & Therapeutics, RapidPulse, Clearside Biomedical, 410 Medical. These companies were founded in 2020 or later.